Correlation Between Integrated Biopharma and MusclePharm
Can any of the company-specific risk be diversified away by investing in both Integrated Biopharma and MusclePharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integrated Biopharma and MusclePharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integrated Biopharma and MusclePharm, you can compare the effects of market volatilities on Integrated Biopharma and MusclePharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integrated Biopharma with a short position of MusclePharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integrated Biopharma and MusclePharm.
Diversification Opportunities for Integrated Biopharma and MusclePharm
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Integrated and MusclePharm is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Integrated Biopharma and MusclePharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MusclePharm and Integrated Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integrated Biopharma are associated (or correlated) with MusclePharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MusclePharm has no effect on the direction of Integrated Biopharma i.e., Integrated Biopharma and MusclePharm go up and down completely randomly.
Pair Corralation between Integrated Biopharma and MusclePharm
Given the investment horizon of 90 days Integrated Biopharma is expected to under-perform the MusclePharm. But the otc stock apears to be less risky and, when comparing its historical volatility, Integrated Biopharma is 31.67 times less risky than MusclePharm. The otc stock trades about -0.18 of its potential returns per unit of risk. The MusclePharm is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.30 in MusclePharm on September 1, 2024 and sell it today you would lose (0.30) from holding MusclePharm or give up 100.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 9.43% |
| Values | Daily Returns |
Integrated Biopharma vs. MusclePharm
Performance |
| Timeline |
| Integrated Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| MusclePharm |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Integrated Biopharma and MusclePharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Integrated Biopharma and MusclePharm
The main advantage of trading using opposite Integrated Biopharma and MusclePharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integrated Biopharma position performs unexpectedly, MusclePharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will offset losses from the drop in MusclePharm's long position.| Integrated Biopharma vs. Premier Foods Plc | Integrated Biopharma vs. Torque Lifestyle Brands | Integrated Biopharma vs. Naturally Splendid Enterprises | Integrated Biopharma vs. Aryzta AG PK |
| MusclePharm vs. Chimerix | MusclePharm vs. Apogee Therapeutics, Common | MusclePharm vs. Canlan Ice Sports | MusclePharm vs. United Parks Resorts |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |